NEM vs. AXSM
NEM (Newmont Corporation) and AXSM (Axsome Therapeutics, Inc.) are both stocks. NEM operates in Gold (Basic Materials), while AXSM operates in Biotechnology (Healthcare). Over the past 10 years, NEM returned 10.07%/yr vs 39.83%/yr for AXSM. Their 0.06 correlation means their historical movements had little consistent relationship.
Performance
NEM vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NEM achieves a -5.74% return, which is significantly lower than AXSM's 19.36% return. Over the past 10 years, NEM has underperformed AXSM with an annualized return of 10.07%, while AXSM has yielded a comparatively higher 39.83% annualized return.
NEM
- 1D
- -2.14%
- 1M
- 0.44%
- 6M
- -16.23%
- YTD
- -5.74%
- 1Y
- 52.51%
- 3Y*
- 33.89%
- 5Y*
- 11.52%
- 10Y*
- 10.07%
- ALL TIME*
- 4.83%
AXSM
- 1D
- -7.10%
- 1M
- -9.42%
- 6M
- 18.31%
- YTD
- 19.36%
- 1Y
- 115.02%
- 3Y*
- 41.26%
- 5Y*
- 35.01%
- 10Y*
- 39.83%
- ALL TIME*
- 34.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $153.10M | $171.36M | $209.26M | |
| $671.95M | $683.19M | $803.32M |
NEM vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NEM Newmont Corporation | -5.74% | 172.82% | -7.83% | -8.76% | -20.77% | 7.40% | 40.28% | 30.52% | -6.15% | 10.91% |
AXSM Axsome Therapeutics, Inc. | 19.36% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
Correlation
The correlation between NEM and AXSM is 0.18, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.18 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.11 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.08 |
Correlation (All Time) Calculated using the full available price history since Nov 19, 2015 | 0.06 |
The correlation between NEM and AXSM shifts across timeframes, from 0.06 (all time) to 0.18 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
NEM:
$98.74B
AXSM:
$11.22B
NEM:
$7.88
AXSM:
-$3.72
NEM:
5.34
AXSM:
15.58
NEM:
2.82
AXSM:
204.46
NEM:
$19.13B
AXSM:
$708.24M
NEM:
$10.94B
AXSM:
$655.82M
NEM:
$14.81B
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NEM vs. AXSM — Risk / Return Rank
NEM
AXSM
NEM vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Newmont Corporation (NEM) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NEM | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.58 | ||
| Sortino ratioReturn per unit of downside risk | -2.38 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.47 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | 6.25 | -4.61 |
| Martin ratioReturn relative to average drawdown | 3.61 | 18.02 | -14.40 |
Loading charts...
Drawdowns
NEM vs. AXSM - Drawdown Comparison
The maximum NEM drawdown since its inception was -81.30%, smaller than the maximum AXSM drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for NEM and AXSM.
Loading charts...
Drawdown Indicators
| NEM | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.30% | -86.65% | +5.35% |
Max Drawdown (1Y)Largest decline over 1 year | -32.10% | -18.50% | -13.60% |
Max Drawdown (3Y)Largest decline over 3 years | -36.57% | -32.69% | -3.88% |
Max Drawdown (5Y)Largest decline over 5 years | -62.40% | -61.08% | -1.32% |
Max Drawdown (10Y)Largest decline over 10 years | -62.40% | -81.26% | +18.86% |
Current DrawdownCurrent decline from peak | -28.67% | -14.57% | -14.10% |
Average DrawdownAverage peak-to-trough decline | -41.33% | -39.06% | -2.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.57% | 6.41% | +8.16% |
Volatility
NEM vs. AXSM - Volatility Comparison
The current volatility for Newmont Corporation (NEM) is 11.58%, while Axsome Therapeutics, Inc. (AXSM) has a volatility of 14.94%. This indicates that NEM experiences smaller price fluctuations and is considered to be less risky than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NEM | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.58% | 14.94% | -3.36% |
Volatility (6M)Calculated over the trailing 6-month period | 37.40% | 28.72% | +8.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.45% | 42.96% | +4.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.35% | 70.11% | -31.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.74% | 90.38% | -54.64% |
Dividends
NEM vs. AXSM - Dividend Comparison
NEM's dividend yield for the trailing twelve months is around 1.09%, while AXSM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NEM Newmont Corporation | 1.09% | 1.00% | 2.69% | 3.87% | 4.66% | 3.55% | 1.74% | 3.31% | 1.62% | 0.67% | 0.37% | 0.56% |
Financials
NEM vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Newmont Corporation and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NEM and AXSM have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXSM has higher volatility (14.94%) compared to NEM (11.58%). In terms of maximum drawdown, NEM dropped -81.30% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (2.69 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NEM and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer